Brief: BB Biotech 2022 Net Loss CHF 358 MLN
Feb 17 (Reuters) - BB BIOTECH AG BION.S :
* BB BIOTECH AG PUBLISHES ITS 2022 ANNUAL REPORT
* NET LOSS IN 2022 WAS CHF 358 MILLION
* FOR FULL YEAR, BB BIOTECH'S TOTAL SHARE RETURN WAS -24.3%
IN CHF
AND -19.0% IN EUR, SUBSTANTIALLY BEHIND PORTFOLIO PERFORMANCE OF
-11.0% IN CHF, -6.7% IN EUR AND -12.1% IN USD
Further company coverage: BION.S
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Bb Biotech AG
See all newsBrief: BB Biotech Reports Net Profit Of CHF 451 Mln In Q2 2026
Switzerland's BB Biotech Q1 net loss narrows amid portfolio rotation
Brief: BB Biotech Reports Q1 Net Loss Of CHF 21 Million
Brief: BB BIOTECH Q1 Net Income CHF -21 Million
Brief: BB Biotech Says All Proposals Of Board Of Directors Approved At AGM